Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Southern Medical Journal
|
September 1, 1981
Phenytoin-induced interstitial nephritis
E W Hoffman
Drug Intelligence & Clinical Pharmacy
|
September 1, 1982
Basics of cardiovascular hemodynamic monitoring
E W Hoffman
Therapeutic Drug Monitoring
|
January 1, 1983
A prospective evaluation of therapeutic drug monitoring
H I Bussey, E W Hoffman
Annals of Internal Medicine
|
October 1, 1994
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial
D W Maher, G J Lieschke, M Green, et al.
Preparative Biochemistry & Biotechnology
|
May 11, 2005
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions
R Murphy, S Green, G Ritter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial
A M Scott, F T Lee, W Hopkins, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Southern Medical Journal
|
September 1, 1981
Phenytoin-induced interstitial nephritis
E W Hoffman
Drug Intelligence & Clinical Pharmacy
|
September 1, 1982
Basics of cardiovascular hemodynamic monitoring
E W Hoffman
Therapeutic Drug Monitoring
|
January 1, 1983
A prospective evaluation of therapeutic drug monitoring
H I Bussey, E W Hoffman
Annals of Internal Medicine
|
October 1, 1994
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial
D W Maher, G J Lieschke, M Green, et al.
Preparative Biochemistry & Biotechnology
|
May 11, 2005
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions
R Murphy, S Green, G Ritter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2001
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial
A M Scott, F T Lee, W Hopkins, et al.
Page
of 1